SpinTech MRI, creators of FDA-cleared STAGE (STrategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) platform that speeds and improves the diagnosis and treatment of Parkinson's, Alzheimer's, dementia and other neurological diseases, announced $6.5 million Series A financing.

Led by Level 8 Ventures and Genesis Innovation Group's Cultivate(MD) Capital Fund, the funding will be used to expand deployments of STAGE software for neurologists, radiologists and researchers.